Sage Rhino Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-453
| Closed | -$220K | – | 296 |
|
|
2025
Q1 | $220K | Buy |
+453
| New | +$220K | 0.05% | 219 |
|
|
2024
Q4 | – | Sell |
-520
| Closed | -$242K | – | 296 |
|
|
2024
Q3 | $242K | Sell |
520
-26
| -5% | -$12.1K | 0.05% | 205 |
|
|
2024
Q2 | $256K | Sell |
546
-12
| -2% | -$5.63K | 0.06% | 190 |
|
|
2024
Q1 | $233K | Buy |
558
+5
| +0.9% | +$2.09K | 0.06% | 198 |
|
|
2023
Q4 | $225K | Sell |
553
-54
| -9% | -$22K | 0.06% | 192 |
|
|
2023
Q3 | $211K | Sell |
607
-4
| -0.7% | -$1.39K | 0.06% | 193 |
|
|
2023
Q2 | $215K | Buy |
+611
| New | +$215K | 0.06% | 193 |
|
|
2022
Q3 | – | Sell |
-934
| Closed | -$263K | – | 203 |
|
|
2022
Q2 | $263K | Sell |
934
-549
| -37% | -$155K | 0.1% | 158 |
|
|
2022
Q1 | $387K | Sell |
1,483
-88
| -6% | -$23K | 0.12% | 144 |
|
|
2021
Q4 | $345K | Buy |
1,571
+27
| +2% | +$5.93K | 0.1% | 147 |
|
|
2021
Q3 | $280K | Buy |
1,544
+23
| +2% | +$4.17K | 0.09% | 155 |
|
|
2021
Q2 | $307K | Buy |
1,521
+8
| +0.5% | +$1.62K | 0.09% | 150 |
|
|
2021
Q1 | $325K | Buy |
1,513
+265
| +21% | +$56.9K | 0.11% | 132 |
|
|
2020
Q4 | $295K | Buy |
1,248
+116
| +10% | +$27.4K | 0.12% | 133 |
|
|
2020
Q3 | $308K | Buy |
1,132
+91
| +9% | +$24.8K | 0.15% | 113 |
|
|
2020
Q2 | $302K | Buy |
1,041
+27
| +3% | +$7.83K | 0.16% | 109 |
|
|
2020
Q1 | $241K | Sell |
1,014
-6
| -0.6% | -$1.43K | 0.17% | 106 |
|
|
2019
Q4 | $234K | Buy |
+1,020
| New | +$234K | 0.13% | 130 |
|